Hematopoietic Stem Cell TransplantationTransplantation, AutologousTransplantation ConditioningPeripheral Blood Stem Cell TransplantationHematopoietic Stem CellsTransplantation, HomologousHematologic NeoplasmsMultiple MyelomaStem Cell TransplantationMelphalanTreatment OutcomeCombined Modality TherapyGraft vs Host DiseaseDisease-Free SurvivalRetrospective StudiesLymphoma, Non-HodgkinMyeloablative AgonistsSurvival RateWhole-Body IrradiationStem CellsGraft SurvivalBone Marrow TransplantationCyclophosphamideAntigens, CD34Salvage TherapyRemission InductionHematopoietic Stem Cell MobilizationRecurrenceTransplantation ChimeraTissue DonorsImmunosuppressive AgentsSurvival AnalysisCord Blood Stem Cell TransplantationHistocompatibility TestingBusulfanAntineoplastic Combined Chemotherapy ProtocolsHematopoiesisHistocompatibilityLeukemiaGraft vs Leukemia EffectChimerismLiver TransplantationPrognosisCell DifferentiationBone Marrow CellsHematologic DiseasesHLA AntigensGraft vs Tumor EffectAntineoplastic AgentsMesenchymal Stem Cell TransplantationLeukemia, Myeloid, AcuteHepatic Veno-Occlusive DiseaseVidarabineCell TransplantationTime FactorsSiblingsMyelodysplastic SyndromesTransplantation ImmunologyUnrelated DonorsCell LineageFlow CytometryMice, Inbred C57BLTransplantation, IsogeneicStem Cell NicheEmbryonic Stem CellsBone MarrowAdult Stem CellsT-LymphocytesSevere Combined ImmunodeficiencyPrecursor Cell Lymphoblastic Leukemia-LymphomaKidney TransplantationLymphocyte TransfusionGranulocyte Colony-Stimulating FactorFetal BloodColony-Forming Units AssayLeukemia, Myelogenous, Chronic, BCR-ABL PositiveCytomegalovirus InfectionsAnemia, AplasticAntilymphocyte SerumLymphocyte DepletionCells, CulturedGraft RejectionFollow-Up StudiesAcute DiseaseCell SeparationAllograftsDonor SelectionImmunosuppressionMesenchymal Stromal CellsCell ProliferationOpportunistic InfectionsLymphoproliferative DisordersImmunocompromised HostMultipotent Stem CellsPluripotent Stem CellsLeukemia, MyeloidStem Cell FactorHeart TransplantationCytarabineTransplantation